CRY ANALYSIS
Providing parents and pediatricians the tools to monitor infants. Better.
Our system is being designed to provide continuous non-invasive monitoring of infants’ health, while at their homes. From translating the meaning of baby cries to early detection of potential neurodevelopmental disorders and pathologies.
RESEARCH
Cry Analysis
Using a comprehensive multimodal approach, we’ve investigated infant cries, analyzing various aspects such as acoustics, electroencephalography (EEG) signals, regional cerebral oxygen saturation (NIRS), facial expressions, and other specific parameters. All these studies have helped us develop our advanced Cry Analysis technology.
RESEARCH
Clinical Studies
Our research is studying how the acoustic signal conceals the cause of many infant neurodevelopmental disorders and pathologies, such as autism, specific language impairments, hearing disorders, hyperactivity or sudden infant death among others. This opportunity opens the possibility to a much improved preventive infant healthcare.
TECHNOLOGY
AMSI: Acoustic Multi-Stage Interpreter
Baby crying is the universal language newborns use to communicate. We use artificial intelligence and sound recognition to analyse infant’s cries sounds for parents and pediatricians. Our pioneering deep learning sound based solution is more accurate than any other competing technology.
User Feedback:
Would buy a product which includes our cry analysis technology
Say Zoundream makes it easier to be a parent
Rate our solution 7 or more - Resulting in a NPS score of +62
A part of:
Supported by:
Featured in:
Latest News:
Zoundream presenting latest research at CEPAS2026
02 November 2026 - Just back from CEPAS2026 in Lyon, where our co-founder Ana Laguna Pradas represented Zoundream and presented our latest findings in the AI and Innovation in Neonatology poster session.
Zoundream receives support from Red.es for the NEODREAM project
20 October 2026 - Zoundream has been the beneficiary of a grant from Red.es, within the AI Health Network 2025 call, which promotes artificial intelligence projects with an impact on health.
Santander X Spain Award | Startup & Scaleup 2026
19 October 2026 - Zoundream is a national finalist in the Santander X Spain Award | Startup & Scaleup 2026. Our co-founder Ana Laguna Pradas will take the stage at the pitch final at Valencia Digital Summit tomorrow, October 21st.